1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, June 2017 (p20)

Biotechnology Analysis & Statistics in the United States, June 2017 (p20)

571-600 of about 1700 reports

Purchase Reports From Reputable Market Research Publishers

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017 Summary According to the recently published report 'N Sulphoglucosamine ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States

Gaucher Disease - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • June 2017
  • by Global Markets Direct

Gaucher Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Pathology, Biopharmaceutical, Healthcare
  • Countries : United States, World

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H1 2017 Summary According to the recently published report 'Protein Phosphatase 2A - Pipeline Review, H1 2017'; Protein Phosphatase 2A (PP2A ...

  • Industries : Therapy, Pathology, Cancer
  • Countries : United States

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • June 2017
  • by Global Markets Direct

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency - Pipeline ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Myelodysplastic Syndrome - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • June 2017
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome - Pipeline Review, H1 2017, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States

Radius Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Radius Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Radius Health, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Healthcare
  • Countries : United States

WaferGen Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

WaferGen Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s WaferGen Biosystems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances ...

  • Countries : United States

Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Illumina, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Countries : United States

Lonza Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Lonza Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Lonza Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Pharmaceutical
  • Countries : United States

ProMetic Life Sciences Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

ProMetic Life Sciences Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s ProMetic Life Sciences Inc. Mergers & Acquisitions (M&A), Partnerships ...

  • Countries : United States, Canada, United Kingdom

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Navidea Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Navidea Biopharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States

Innoviva, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Innoviva, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Innoviva, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Pharmaceutical
  • Countries : United States

Array BioPharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Array BioPharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Array BioPharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States

BioTime, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

BioTime, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s BioTime, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Countries : United States

Pacific Biosciences of California, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Pacific Biosciences of California, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Pacific Biosciences of California, Inc. Mergers & Acquisitions ...

  • Industries : Genomics
  • Countries : United States

Agilent Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Agilent Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Agilent Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & ...

  • Industries : Genomics
  • Countries : United States

Marina Biotech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Marina Biotech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Marina Biotech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Biotechnology
  • Countries : United States

Soligenix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Soligenix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Soligenix, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Pharmaceutical
  • Countries : United States

RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Pharmaceutical
  • Countries : United States

Northwest Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Northwest Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Northwest Biotherapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States, United Kingdom

Cellectis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2017
  • by MarketLine

Cellectis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Cellectis S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Countries : United States, France

Global Autologous Cell Therapy Market 2017-2021

  • $ 3500
  • Industry report
  • June 2017
  • by Infiniti Research Limited

About Autologous Cell Therapy Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, ...

  • Industries : Biological Therapy
  • Countries : World, United States, Japan

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • June 2017
  • by GlobalData

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026 Summary GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland (CGF, 2003). The ...

  • Industries : Health Services, Biopharmaceutical
  • Countries : Japan, United States

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • May 2017
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States

Non-Hodgkin Lymphoma - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • May 2017
  • by Global Markets Direct

Non-Hodgkin Lymphoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H1 2017, provides an ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Bone Sarcoma Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • May 2017
  • by GlobalData

Bone Sarcoma Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bone Sarcoma Global Clinical Trials Review, H1, 2017" provides an overview of Bone Sarcoma clinical ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World, United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.